Myo-inositol Versus Metformin Administration in Post-menopausal Women With Metabolic Syndrome
NCT01046500
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Metabolic Syndrome
Interventions
DIETARY_SUPPLEMENT:
myo-inositol
DRUG:
Metformin
Sponsor
University of Messina